Tamar Elkeles - 29 Apr 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)

Reporting relationship: Director
Issuer ticker: VRAR
Reported as of: 29 Apr 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2024, 12:58:26 UTC
Prior SEC filing: 18 Oct 2021
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Tamar Elkeles

Key filing fact

Tamar Elkeles filed Form 4 for Glimpse Group, Inc. (VRAR) on 04 Jun 2024.

Key facts

This page summarizes Tamar Elkeles's Form 4 filing for Glimpse Group, Inc. (VRAR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2024, 12:58.

Change

Previous filing in this sequence was filed on 18 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRAR transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value: $0
Shares: +20,000
Change %
Price: $0.000000
Shares after: 20,000
Date: 29 Apr 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $2.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested.